Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies. - Wikidata - awgldk - TriplyDB

Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.

Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.

http://www.wikidata.org/entity/Q36208191

about

Both Epistasis and Diversifying Selection Drive the Structural Evolution of the Ebola Virus Glycoprotein Mucin-Like Domain A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?The ongoing evolution of antibody-based treatments for Ebola virus infection.Monoclonal antibodies for the treatment of Ebola virus disease.Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry Discovery of an antibody for pan-ebolavirus therapy In silico-based vaccine design against Ebola virus glycoprotein Considerations for Use of Investigational Drugs in Public Health Emergencies.Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies.Potent neutralizing monoclonal antibodies against Ebola virus infection Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic.Structures of Ebola virus GP and sGP in complex with therapeutic antibodies.Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1.Clinical Evaluation of Ebola Virus Disease Therapeutics.Initiating a watch list for Ebola virus antibody escape mutations.Spontaneous Mutation at Amino Acid 544 of the Ebola Virus Glycoprotein Potentiates Virus Entry and Selection in Tissue Culture.Discovering Drugs for the Treatment of Ebola Virus.Epitope mapping of Ebola virus dominant and subdominant glycoprotein epitopes facilitates construction of an epitope-based DNA vaccine able to focus the antibody response in mice.Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability.Analysis of Ebola virus polymerase domains to find strain-specific differences and to gain insight on their pathogenicity.Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus.An inter-residue network model to identify mutational-constrained regions on the Ebola coat glycoprotein.[Epidemiological aspects of Ebola virus disease in Guinea (december 2013-april 2016)].B and T Cell Epitope-Based Peptides Predicted from Evolutionarily Conserved and Whole Protein Sequences of Ebola Virus as Vaccine Targets.A Biologically-validated HCV E1E2 Heterodimer Structural Model.Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody binding.Unveiling a Drift Resistant Cryptotope within Marburgvirus Nucleoprotein Recognized by Llama Single-Domain Antibodies.Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins.Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region.Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection Candidate medical countermeasures targeting Ebola virus cell entry Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein Generation of therapeutic antisera for emerging viral infections Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors

P2860

Q28596689-07DBA99F-D52F-4A58-8903-B8A0B66B24C1 Q29994671-25353F5B-E730-4015-BBAF-72CF859382AF Q30235022-161EEAA1-6542-4316-895F-E716414A0F47 Q30245073-00EC2C27-E8C0-45C1-86E0-1993716A45A2 Q30276615-596200AE-BE3E-40A5-8832-1EFD38BF67E9 Q30385927-7A1DB510-A47E-41FA-A8AF-5DC2A23F720B Q30843053-4EA55B7C-D62F-4C6C-A5AB-964717588B2A Q33840242-F714D360-B5BF-49A4-9C54-571E56E43AFE Q36178499-F47B0E50-96BC-4BF8-A33F-A9119F3785EE Q36903111-C8219759-89BB-4FC3-B555-7C7D086D8BF0 Q36913606-941E2FAD-64FF-411D-836B-696D9F3D8A04 Q37134982-54C8284C-9FBF-49E1-A4AB-DB955655B5EC Q37213985-B2736F06-776F-483C-9058-A1CEDF1AAEF2 Q37522507-877C3DC5-96C7-49A5-A7EA-D86649DAD589 Q38617605-7A5D3AA7-4855-4A31-84F4-C19EAAD096AF Q38647393-3F66095F-567E-495D-939B-2C5A168537C1 Q38702384-2A4F6DE8-7F20-43F1-98C8-5AD08C36A5CE Q40039706-2D76FDC8-E9AF-45F3-B5B1-CEA3E9A57D1D Q40048667-DCA36E47-469E-4AC3-B555-63962069207A Q40056179-76DC4762-38A0-4D9E-87CA-492D6DF671F6 Q40058733-69CDFC4C-FE63-425A-BEA3-A23C3315770A Q40061368-2A395E9E-2A1C-4F9B-9939-2484B1F15F53 Q40061573-F616A5BC-476F-44DF-A465-94122FA3628C Q40095280-18B08BDF-B3AD-4261-8790-880696CF113E Q40115467-EEF01E4C-F084-4253-9321-DFAAC8D43DF8 Q40288437-63AC7D2E-294C-4716-B810-812ECD28C18F Q41596421-B9F6FBB6-0855-40F9-A556-F84AD610AC9C Q42371906-8FE6EB81-4BF1-45F4-B7C7-7C50DC3A78FB Q51784478-F35950DC-949B-446B-A557-1AA06880B1AF Q54218743-F2C720D5-A82A-4BD7-B051-C664227FB0B9 Q56558172-D8DDDF9C-78AA-40B4-B3A1-7A060CBDE668 Q56763004-A7DCCFCE-5815-4195-921A-B9211C172EB5 Q56766050-96144CEE-CAFF-4A98-AF86-D08FAEF95E2D Q56897586-69309741-3283-4E09-B062-C005DFF0D078 Q57483199-E1A0C320-F6C7-4A16-B16F-A4FAE523CD5D Q58779740-3676A7D9-E1C9-4D7D-A21F-7E37A9A8B8D9

P2860

Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.

http://www.wikidata.org/entity/Q36208191

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Mechanism of Binding to Ebola ...... nd MB-003 Cocktail Antibodies.

@ast

Mechanism of Binding to Ebola ...... nd MB-003 Cocktail Antibodies.

@en

type

label

Mechanism of Binding to Ebola ...... nd MB-003 Cocktail Antibodies.

@ast

Mechanism of Binding to Ebola ...... nd MB-003 Cocktail Antibodies.

@en

prefLabel

Mechanism of Binding to Ebola ...... nd MB-003 Cocktail Antibodies.

@ast

Mechanism of Binding to Ebola ...... nd MB-003 Cocktail Antibodies.

@en

P1433

Q36208191-9132E3F7-47CE-48A9-8CA5-98BB4B1D9657

P1476

Q36208191-AD0A18BC-C448-41E9-B19D-F374F35109B9

P2093

Q36208191-2597844B-3ABF-4355-A1A2-E5DE534AF2D2

Q36208191-29E602E8-12A9-434B-B5F1-21B9C9890209

Q36208191-67BAA217-CBDE-4D92-B395-4AF6D7263EF3

Q36208191-9347480E-0354-4E14-9ACF-9266227773EC

Q36208191-984E7A1F-40C2-4C98-BAED-4397033F04B0

Q36208191-C91FFB43-262F-418D-8264-920BDFA1FE00

Q36208191-DCB01E7D-A600-4604-B504-E448C43807DA

Q36208191-FE754C39-E8E9-4320-B25B-676E6CA7BB94

P2860

Q36208191-07D67B59-B661-4BC8-A5A5-8481637A1E3A

Q36208191-0F23DD3A-4E14-4B58-AAD1-5CA64BBC141D

Q36208191-13D15F48-876D-411E-AABB-ABFF44986C47

Q36208191-25050BBC-B10E-4956-AF5C-73F70313E322

Q36208191-3129851E-B8EF-45B9-984D-33BA50F830CE

Q36208191-3272847C-76DF-477C-969D-2C6826F8C99A

Q36208191-3BC4690D-FB19-4505-943D-EC4D3EDBA79A

Q36208191-40395332-58B4-4316-8DAD-5AAE4EE96778

Q36208191-42B9B6F8-6BA8-4DF7-8A0F-CE5A5C666BCB

Q36208191-43855BB4-CE5B-42B7-8C7A-1F98735EE3FD

P304

Q36208191-C9BB6DA7-528D-41E2-B7FF-F07B1E53BEA8

P31

Q36208191-BA102F1F-FABA-4E5E-B378-E8F2B35DE825

P356

Q36208191-C9405A50-6468-4402-9A94-1CC0BFF58502

P407

Q36208191-9F3C9004-B17C-4C59-BFA7-E26F36DA3945

P433

Q36208191-2EFFB2F2-B5D5-43AC-82BC-4A88CA0535DC

P478

Q36208191-5410059F-760D-4C8B-B028-58DF0423FB62

P577

Q36208191-64A1BB64-F362-4B98-898A-509792DBC8E0

P5875

Q36208191-B7417430-651D-4632-B7F7-9BA27900BDDF

P698

Q36208191-0986EB99-E64F-4EF3-87E0-C1FE84C68BAD

P921

Q36208191-06C35F8D-ED81-4057-A7A4-62013B4A23D6

Q36208191-EC725CD2-A136-41F3-A10D-016DD50478DC

P932

Q36208191-8B59048D-4AE7-4C41-B6B7-BEF8EE0148AC

P356

P1433

Journal of Virology

P1476

Mechanism of Binding to Ebola ...... nd MB-003 Cocktail Antibodies.

@en

P2093

Benjamin J Doranz

http://www.w3.org/2001/XMLSchema#string

Christopher Bryan

http://www.w3.org/2001/XMLSchema#string

Edgar Davidson

http://www.w3.org/2001/XMLSchema#string

Jennifer M Pfaff

http://www.w3.org/2001/XMLSchema#string

Joseph B Rucker

http://www.w3.org/2001/XMLSchema#string

Manu Mabila

http://www.w3.org/2001/XMLSchema#string

Rachel H Fong

http://www.w3.org/2001/XMLSchema#string

Trevor Barnes

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical management of filovirus-infected patients

Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak

Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb

Atomic-level mapping of antibody epitopes on a GPCR

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy

A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes

Ebola virus vaccines: an overview of current approaches

Structural basis for differential neutralization of ebolaviruses

Complex of a Protective Antibody with Its Ebola Virus GP Peptide Epitope: Unusual Features of a Vλx Light Chain

P304

10982-10992

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01490-15

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281340431

http://www.w3.org/2001/XMLSchema#string

P698

26311869

http://www.w3.org/2001/XMLSchema#string

P921

P932

4621129

http://www.w3.org/2001/XMLSchema#string